e_A160182 1..1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.




(Incorporated in the Hong Kong with limited liability)

(Stock Code: 648)


SUSPENSION OF TRADING


At the request of China Wah Yan Healthcare Limited (the ''Company''), trading in the securities of the Company on The Stock Exchange of Hong Kong Limited will be suspended with effect from 9 : 00 a.m. on Thursday, 11 February 2016 pending the release of an announcement in relation to a potential very substantial acquisition and pursuant to the Code on Takeovers and Mergers.


By Order of the Board of

China Wah Yan Healthcare Limited Chan Ka Chung

Chairman


Hong Kong, 11 February 2016


As at the date of this announcement, the board of directors of the Company comprises three executive directors, namely Mr. Chan Ka Chung, Mr. Cheung Wai Kwan and Mr. Wang Jianguo; and four independent non-executive directors, namely, Mr. Chan Yee Ping, Michael, Ms. Hu Xuezhen, Mr. Lam Chun Ho and Ms. Wu Yan.

China Wah Yan Healthcare Limited issued this content on 11 February 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 February 2016 04:21:09 UTC

Original Document: http://www.chinarenji.com/upload/AC/2016/e_20160211.pdf